Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00844285 · ClinicalTrials.gov registry record
SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
A clinical trial, sponsored by UCB Biosciences.
- Completed
- Registry status
- 3,072
- Enrollment target
NCT00844285 is a clinical trial that has completed, run by UCB Biosciences. The registered enrollment target is 3,072 participants.
The verdict
NCT00844285 has completed, sponsored by UCB Biosciences.
- COMPLETED
- Registry status
- 3,072 participants
- Enrollment target
Study Summary
The purpose of this study is to monitor safety outcomes of patients who have taken Cimzia® as compared to a non- Cimzia® control population. The SECURE Registry's target enrollment is 3045 patients and it's objective is to monitor patients for approximately 8 years.
Interventions
- DRUG Cimzia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,072 participants |
| Start Date | 2009-01-30 |
| Est. Completion | 2020-08-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00844285
The ClinicalTrials.gov registry entry for NCT00844285 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,072 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UCB Biosciences, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cimzia is the first listed.
NCT00844285 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00844285 about?
NCT00844285 is a clinical study titled "SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry". The purpose of this study is to monitor safety outcomes of patients who have taken Cimzia® as compared to a non- Cimzia® control population. The SECURE Registry's target enrollment is 3045 patients and it's objective is to monitor patients for approximately 8 years.
What is the current status of trial NCT00844285?
This trial is currently completed. The enrollment target is 3,072 participants. The study started on 2009-01-30. Estimated completion is 2020-08-21.
What interventions are being tested in trial NCT00844285?
The interventions under investigation include: Cimzia (DRUG).
Who is sponsoring clinical trial NCT00844285?
This trial is sponsored by UCB Biosciences, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.